Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 24Lung Neoplasms 12Neoplasms 5Colorectal Neoplasms 5Neoplasm Metastasis 4Advanced Solid Tumors 3Pancreatic Neoplasms 2Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation 2Venous Thromboembolism 1Thoracic Neoplasms 1Solid Tumor, Adult 1Solid Tumor 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Ovarian Neoplasms 1Noonan Syndrome 1Non-small Cell Lung Cancer Metastatic 1Non Small Lung Cancer 1Neoplasms by Site 1Mesothelioma 1Lung Diseases 1KRAS p.G12C Mutant Advanced Solid Tumors 1KRAS p, G12c Mutated /Advanced Metastatic NSCLC 1Hereditary Sensory and Autonomic Neuropathies 1Healthy Participants 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Efficacy 1Carcinoma 1Bronchial Neoplasms 1

Interventions

Rosuvastatin Calcium 5capivasertib 2Digoxin 2sotorasib 1ibrutinib 1Midazolam 1Dextromethorphan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Healthy Participants × sotorasib × Clear all
NCT05045638 2023-08-14

Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin in Healthy Participants

Amgen

Phase 1 Completed
13 enrolled 14 charts

Healthy Participants

Data powered by HemOnc (CC BY 4.0) Colophon âš¡